[Corrigendum] Phospho‑valproic acid inhibits pancreatic cancer growth in mice: Enhanced efficacy by its formulation in poly‑(L)‑lactic acid‑poly(ethylene glycol) nanoparticles
- Authors:
- Published online on: October 5, 2018 https://doi.org/10.3892/ijo.2018.4584
- Pages: 2800-2800
-
Copyright : © Mattheolabakis et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article
GEORGE MATTHEOLABAKIS, RUIXUE WANG, BASIL RIGAS and GERARDO G. MACKENZIE
Int J Oncol 51:[Related article:] 1035–1044, 2017
Subsequently to the publication of the aobve article, the authors have realized that they overlooked including a 'Competing Interests' section. This should have been included in the paper as follows: 'GM, RW and GGM declare they have no competing interests. BR has an equity position in Medicon Pharmaceuticals, Inc., the company that provided the test agent'.
The authors regret that this statement was not included in the paper, and apologize for any inconvenience caused.
